What Happened?
Shares of medical device company LeMaitre Vascular (NASDAQ: LMAT) fell 18.6% in the morning session after the company reported second-quarter results that missed analyst expectations and provided a weak forecast for the upcoming quarter.
For the second quarter, LeMaitre's revenue of $70.38 million missed analysts' estimates of $71.61 million, while its earnings per share of $0.74 also fell short of the $0.81 consensus.
Compounding the disappointment, the company's third-quarter revenue guidance of $67.3 million came in about 3% below estimates. LeMaitre also lowered its full-year revenue forecast to $276.3 million from $280 million and issued full-year earnings guidance that also missed Wall Street's expectations.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy LeMaitre? Access our full analysis report here, it’s free.
What Is The Market Telling Us
LeMaitre’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. Moves this big are rare for LeMaitre and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 5 months ago when the stock gained 16.8% on the news that the company reported strong fourth-quarter 2025 results that surpassed Wall Street's expectations for both revenue and earnings. The medical device provider posted sales of $64.45 million, a 15.7% increase from the same period in the previous year. Earnings per share (EPS) grew significantly to $0.68, up from $0.49 in the prior year's quarter and beating analyst forecasts. The company's profitability also saw a notable lift, with its operating margin expanding to 29.2% from 23.1% a year ago. Looking ahead, LeMaitre offered a bright outlook, providing first-quarter revenue guidance that was ahead of consensus and a full-year 2026 GAAP EPS forecast of $2.91 at the midpoint, which was well above market predictions.
LeMaitre is up 3.6% since the beginning of the year, but at $83.02 per share, it is still trading 29.3% below its 52-week high of $117.39 from April 2026. Investors who bought $1,000 worth of LeMaitre’s shares 5 years ago would now be looking at an investment worth $1,462.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
